language_icon
EN
HI

Entero Healthcare Solutions Share price

ENTERO

1133.2

8.20 (-0.72%)
NSE
BSE
Last updated on 2 Jun, 2026 | 11:51 IST
Today's High

1158.00

Today's Low

1103.70

52 Week Low

944.00

52 Week High

1485.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Entero Healthcare Solutions Chart

Entero Healthcare Solutions Share Key Metrics

Volume
1.40 L
Market Cap
4966.34 CR
LTQ@LTP
1@1133.20
ATP
1128.76
Var Margin
19.39 %
Circuit Range
913.2-1369.6
Delivery %
45.99 %
Value
15.83 CR
ASM/GSM
No
Market Lot
1

Summary

Entero Healthcare Solutions share price is ₹1133.2 as of 2 Jun, 2026. The stock Entero Healthcare Solutions intraday movement has stayed between ₹1103.70 and ₹1158.00, while on a 52-week basis,Entero Healthcare Solutions price 52 week high is ₹1485.00 & its 52 week low is ₹944.00.
In terms of trading activity, Entero Healthcare Solutions has recorded a volume of 140246 shares, The Entero Healthcare Solutions has a market cap of ₹43510937 CR. The stock’s Average Traded Price (ATP) stands at ₹1128.76, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1133.20.
Entero Healthcare Solutions operates within a circuit range of ₹913.20 – ₹1369.60, with a Value of ₹15.83 CR. The Delivery Percentage for the day is 45.99%. Additionally, Entero Healthcare Solutions currently falls under the No framework, and trades with a market lot size of 1.

Entero Healthcare Solutions Fundamentals

View More
P/E Ratio

43.2

P/B Ratio

2.94

Div. Yield

0

Sector P/E

40.39

Sector P/B

2.22

Sec. Div. Yield

78.54

Entero Healthcare Solutions Resistance and Support

Pivot 1160.47

Resistance

First Resistance

1190.84

Second Resistance

1240.27

Third Resistance

1270.64

Support

First Support

1111.04

Second Support

1080.67

Third Support

1031.24

Entero Healthcare Solutions Shareholding Pattern

View More
  • 2024-25
  • 2026-27
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

52.42%

Mutual Fund

10.25%

Insurance

0%

Foreign Institutional Investors

5.14%

Domestic Institutional Investors

6.17%

Retail

26.02%

Others

0%

Total Promoters
MAR '25
52.42%
JUN '25
52.42%
SEP '25
52.42%
DEC '25
52.42%

Entero Healthcare Solutions Corporate Actions

DateAgenda
2026-05-25Audited Results & ESOP
2026-02-12Quarterly Results
2025-11-12Quarterly Results
2025-08-08Quarterly Results
2025-05-27Audited Results
2025-02-12Quarterly Results

Entero Healthcare Solutions News

Entero Healthcare Solutions Ltd - 544122 - Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 2026

Entero Healthcare Solutions clarified investor queries regarding Q4 FY26 results. The company stated that profit attributable to owners was impacted by Rs. 11.4 crore in one-off costs, while an increase in non-controlling interest was due to the 51.51% acquisition of Anand Chemiceutics Private Limited.
May 28 2026 23:22:46

Entero Healthcare Solutions Limited

Entero Healthcare Solutions provided clarifications regarding its Q4 FY26 financial results. The company cited Rs. 11.4 crore in one-off costs from contract closure and provisioning charges affecting profit attributable to owners. Additionally, increased non-controlling interest resulted from a 51.51% stake acquisition in Anand Chemiceutics Private Limited.
May 28 2026 23:21:36

Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Entero Healthcare Solutions has made available the audio recording of its Investors/Analyst Earnings Call held for the audited financial results of Q4 FY26. The transcript will also be uploaded on the company's website in due course, providing full details of the discussion.
May 26 2026 15:28:00

Entero Healthcare Solutions Limited

Entero Healthcare's subsidiary, Sai Pharma Distributors, is set to acquire Vishal Surgicals for Rs. 6.3 crore in cash. This strategic acquisition will expand the company's pharmaceutical and surgical distribution business, with the target recording Rs. 11.6 crore turnover in FY25.
May 25 2026 23:24:53

Entero Healthcare Solutions Ltd - 544122 - The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP ('EY') For The Next Financial Year 2026-27.

Entero Healthcare Board approved its FY26 audited financial results, along with re-appointment of three Independent Directors and Internal Auditor. The board also fixed August 19, 2026 for its 8th Annual General Meeting and approved two small acquisitions.
May 25 2026 21:38:28

Entero Healthcare Solutions Ltd - 544122 - The Grant Of Fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing 'Entero Employee Stock Option Plan 2023'.

Entero Healthcare Board approved its FY26 audited financial results, along with re-appointment of three Independent Directors and Internal Auditor. The board also fixed August 19, 2026 for its 8th Annual General Meeting and approved two small acquisitions.
May 25 2026 21:31:42

Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting May 25, 2026

Entero Healthcare Solutions reported Q4 FY26 cons. revenue up 11.9% YoY to ₹1,909.93 Cr and net profit up 33.2% to ₹45.13 Cr. The board also re-appointed three Independent Directors for five-year terms, re-appointed Ernst & Young LLP as internal auditor for FY27, and approved the acquisition of Vishal Surgicals for up to ₹9.21 Cr, expanding its pharmaceutical distribution business.
May 25 2026 21:05:15

Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

ICICI Prudential Mutual Fund has significantly reduced its shareholding in Entero Healthcare Solutions from 5.015% to 2.161%. This disposal of 12.41 lakh shares occurred through open market transactions.
May 23 2026 10:40:31

Entero Healthcare Solutions Limited

Entero Healthcare Solutions Limited's Board of Directors is scheduled to convene on May 25, 2026. The primary agenda includes the consideration and approval of the audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
May 18 2026 19:02:49

Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements For The Quarter And Year Ended March 31, 2026.

Entero Healthcare Solutions' Board will convene on May 25, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
May 18 2026 18:59:37
Read More

Entero Healthcare Solutions Management

NamePosition
Sanu KapoorVice president- General Counsel, Company Secretary & Compliance Officer
Sujesh VasudevanChairman
View More

Entero Healthcare Solutions FAQs

The Buying Price of Entero Healthcare Solutions share is 1133.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Entero Healthcare Solutions stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Entero Healthcare Solutions, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Entero Healthcare Solutions shares is 43.2. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Entero Healthcare Solutions shares is 2.94. Useful to assess the stock's value relative to its book value.

To assess Entero Healthcare Solutions’s valuation compare Sector P/E, P/B which are 40.39 & 2.22 with sector averages, along with growth rates and financial metrics.

The Market Cap of Entero Healthcare Solutions is 4966.34 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Entero Healthcare Solutions share price is 1485.00 & 944.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Entero Healthcare Solutions belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost